Pitfalls in the diagnosis and management of Lyme disease (Q41713926)

7 October 2017

1 reference

title

Pitfalls in the diagnosis and management of Lyme disease (English)

1 reference

7 October 2017

0 references

L. H. Sigal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9485077

10 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9485077

10 December 2024

publication date

1 February 1998

1 reference

7 October 2017

February 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9485077

full work available at URL

10 December 2024

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9485077

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

https://onlinelibrary.wiley.com/doi/full/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

10 December 2024

published in

Arthritis & Rheumatology

1 reference

7 October 2017

Arthritis and Rheumatism

195–204

February 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9485077

10 December 2024

volume

1 reference

7 October 2017

1 reference

7 October 2017

page(s)

195-204

1 reference

Risk of urban Lyme disease enhanced by the presence of rats

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Epidemiologic and diagnostic studies of patients with suspected early Lyme disease, Missouri, 1990-1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Lyme carditis: cardiac abnormalities of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Lyme Disease Associated with Fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Nervous system Lyme borreliosis--revisited [corrected; erratum to be published]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Cross-reactivity in serological tests for Lyme disease and other spirochetal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Western blotting in the serodiagnosis of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Treatment of the Early Manifestations of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

21 January 2018

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Lyme disease: a review of aspects of its immunology and immunopathogenesis

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

The geographic spread and temporal increase of the Lyme disease epidemic

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Lyme borreliosis in the southern United States: a review

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Population genetic analysis of Borrelia burgdorferi isolates by multilocus enzyme electrophoresis

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Erythema migrans and early Lyme disease

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Bulletin on the rheumatic diseases

10 December 2024

Sigal

1995

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Early disseminated Lyme disease: cardiac manifestations

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Early disseminated Lyme disease: Lyme meningitis

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

The clinical evolution of Lyme arthritis

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Musculoskeletal manifestations of Lyme disease

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

False positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: the value of immunoblot analysis

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

"Chronic Lyme disease" as the incorrect diagnosis in patients with fibromyalgia

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Summary of the first 100 patients seen at a Lyme disease referral center

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Persisting complaints attributed to chronic Lyme disease: possible mechanisms and implications for management

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Ocular manifestations of Lyme disease

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Muscle, reticuloendothelial, and late skin manifestations of Lyme disease

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Borrelia burgdorferi in the nervous system: the new "great imitator".

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Absence of Lyme borreliosis among patients with presumed Bell's palsy

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Diagnosing early Lyme disease

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Current status of laboratory diagnosis for Lyme disease

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Misdiagnosis of Lyme disease: when not to order serologic tests

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

The polymerase chain reaction assay for Borrelia burgdorferi in the diagnosis of Lyme disease

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Current recommendations for the treatment of Lyme disease

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Use of amantadine for chronic fatigue syndrome

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Should we try malariotherapy for Lyme disease?

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Practicing medicine without a license--the new intrusions by Congress

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

The Overdiagnosis of Lyme Disease

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

The overdiagnosis of Lyme disease in children residing in an endemic area

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Changing medical organization and the erosion of trust

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

The impact of managed care on patients' trust in medical care and their physicians

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities

10 December 2024

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Archiv fur Dermatologie und Syphilis

10 December 2024

101

404

Afzelius

1910

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

Journal de medecine de Lyon

10 December 2024

765

Garin

1922

1 reference

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1529-0131(199802)41:2%3C195::AID-ART3%3E3.0.CO;2-Y

10 December 2024

Identifiers

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

1 reference

7 October 2017

1 reference